GCI – Grand Challenges Israel Incentive Program

The Grand Challenges Israel incentive program operates as part of the Grand Challenges in Global Health international initiative. The incentive program is also partnered by Israel’s Agency for International Development Cooperation (MASHAV) and the National Economic Council of the Prime Minister’s Office. 

Goal of the incentive program:
The program supports R&D focused on the humanitarian health challenges that exist in developing countries, with products that also have commercial potential in developed countries. Participation in this incentive program combines charitable acts and services with new business opportunities and the chance to solve global challenges.

Who is the incentive program for?

The incentive program is suitable for companies and entrepreneurs targeting markets in developing countries in the following areas:

Global Health

  • Accessibility of health services
  • Vector control
  • Pregnant women and newborn health
  • Point-of-care diagnostics
  • Infectious disease treatment
  • Public and community health
  • Mental health

Water

  • Water treatment and sanitation
  • Access to clean water

Argitech

  • Post-harvest treatment
  • Irrigation in arid conditions
  • Advanced agriculture

What do you get?

  • Support of 70%, 80% or 90% of the approved budget, up up to a maximum of NIS 500,000.

Why should you apply for this incentive program?

Attractive conditions:
Financing of up to 90% of the budget gives the project an initial push. In addition, the incentive program offers an exemption from the repayment of royalties on the revenues received from target countries.

Exposure to new markets and potential partners: This incentive program creates bridges between entrepreneurs and potential partners in target markets.

Israeli Companies

Israeli companies seeking further information on the requirements and application process to this program, should refer to the Israel Innovation Authority's Hebrew site: https://innovationisrael.org.il/program/2854